Emerging role of primary heterogeneous nucleation in pharmaceutical crystallization

• Published in: Drug development research Vol. 81; no. 1; pp. 3 - 22
• Main Authors: Thakore, Samarth D., Sood, Aaruti, Bansal, Arvind K.
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.02.2020; Wiley Subscription Services, Inc
• Subjects: Crystallization; Manufacturability; Nucleation; Particulates; pharmaceutical application(s); pharmaceutical crystallization; Pharmaceutical industry; Pharmaceuticals; Polymorphism; primary heterogeneous nucleation; Properties (attributes); Surface properties; pharmaceutical application(s); pharmaceutical crystallization; primary heterogeneous nucleation
• ISSN: 0272-4391; 1098-2299
• DOI: 10.1002/ddr.21622

Crystallization is an important and difficult to control unit operation in the pharmaceutical industry. Crystallization can control molecular (i.e., polymorphism) and particulate (i.e., particle size and crystal habit) properties of active pharmaceutical ingredient (API). Moreover, these molecular and particulate properties govern the manufacturability, stability, and biopharmaceutical performance of the API and drug product. Nucleation is a key step and primary heterogeneous nucleation is a common mode of nucleation during crystallization. Hence, it is important to understand the parameters affecting primary heterogeneous nucleation, to achieve desirable properties in crystalline APIs. Primary heterogeneous crystallization has usually been linked to the surface characteristics like topography and functionality of the heteronucleant. The review outlines recent findings in the primary heterogeneous crystallization with specific emphasis on its pharmaceutical applications including regulatory considerations. Molecular‐level mechanisms governing heteronucleation and subsequent outcome in terms of molecular as well as particulate‐level properties of API have also been discussed. Moreover, general guidance for the selection of heteronucleant has also been included. Heterogeneous crystallization is a promising tool for efficient crystallization of API having properties for optimal pharmaceutical performance.